This isn’t about trump. That’s a handy excuse. This is about el Lilly maximising profit before competitor products hit the markets in the next 18 months and generic wegovy hits the markets at a much lower price point, and they start to lose market share, howver I am going to imagine trump will have some choice words as he wanted the USA price down, not other countries up and everyone is blaming him, not el Lilly though , they aren’t blaming him, as they know to do so would cause immediate retribution.
anyone on 5mg or lower for maintenance likely will have limited impact as increase there is only about 40 quid max, it is people on7.5 and above or anyone starting or mid journey who are going to be taken out by this. It is shocking the government can’t stop it when it’s not widely available on the nhs either.
many will move to wegovy, which is manufactured by a danish company, I would assume they maintain price to capture the market share el Lilly will lose, putting it uo will be pointless. As if you’re going to pay that much you will pick mounjaro. Some erroneous info on line that you can’t switch if below 30 bmi but you can and multiple pharmacies now suggesting it.
either way this increase is time limited, when the other products hit the market the price will go down, so this is likely for 18 months max, and is just lining el Lilly’s pockets. It doesn’t help anyone in the here and now. But there is an end in sight. We also need to watch how it plays out, as the big pharmacies won’t want to lose lots of customers, hence why they are allowing the switch, but they also have margin to play with, and can reduce pricing somewhat if they chose.
el Lilly have not covered themselves in glory here and the price they are charging in the USA and similar markets is outrageously high. Trump acted to put a stop to that gouging, and they have just put the price up elsewhere to try to protect their profits.